Mainstream

Zevra Therapeutics GAAP EPS of -$0.06 beats by $0.13, revenue of $20.4M beats by $3.44M

Zevra Therapeutics GAAP EPS of -$0.06 beats by $0.13, revenue of $20.4M beats by $3.44M

Post ContentzvraRead More

You might also be interested in reading 2.5 years since the ETFs launched… and GBTC still charges 1.5% per year (6x market rate).

May 14, 2025
In Mainstream